XRAY

+ Watchlist + Portfolio

DENTSPLY SIRONA Inc.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $8.74
52-Week Range: $8.59 – $14.76
Market Cap: $1.73B
P/E (TTM): —
EPS (TTM): -2.73
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 1.32
PEG Ratio: 0.56
Return on Equity: -33.03%
Return on Assets: 1.96%
Gross Margin: 49.52%
Operating Margin: 9.24%
Profit Margin: -14.99%
Current Ratio: 1.63
Debt/Equity: 1.72
Total Debt: $2.33B
Free Cash Flow: $141.62M
Revenue Growth: -4.10%
Earnings Growth: —
Enterprise Value: $3.82B

XRAY Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$3.92B	$3.96B	$3.79B	$3.68B
Cost of Revenue	$1.79B	$1.88B	$1.83B	$1.84B
Gross Profit	$2.13B	$2.09B	$1.96B	$1.84B
Research & Development	$174.00M	$184.00M	$165.00M	$150.00M
Selling, General & Admin	$1.59B	$1.61B	$1.60B	$1.44B
Operating Expenses	$1.76B	$1.80B	$1.77B	$1.59B
Operating Income	$364.00M	$289.00M	$188.00M	$252.00M
EBITDA	-$662.00M	$249.00M	-$518.00M	-$46.00M
Pretax Income	-$1.05B	-$175.00M	-$936.00M	-$486.00M
Income Tax	-$105.00M	-$43.00M	-$26.00M	$112.00M
Net Income	-$950.00M	-$132.00M	-$910.00M	-$598.00M
Diluted EPS	-4.41	-0.62	-4.48	-3.00
Diluted Shares	215.50M	212.00M	203.20M	199.40M

XRAY Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$365.00M	$334.00M	$272.00M	$326.00M
Receivables	$685.00M	$756.00M	$606.00M	$737.00M
Inventory	$627.00M	$624.00M	$564.00M	$642.00M
Current Assets	$1.89B	$1.97B	$1.75B	$2.02B
Total Assets	$7.64B	$7.37B	$5.75B	$5.43B
Current Liabilities	$1.17B	$1.43B	$1.59B	$1.34B
Long-Term Debt	$1.83B	$1.80B	$1.59B	$2.02B
Total Debt	$2.15B	$2.30B	$2.27B	$2.47B
Total Liabilities	$3.83B	$4.08B	$3.81B	$4.09B
Retained Earnings	$456.00M	$205.00M	-$835.00M	-$1.56B
Shareholders' Equity	$3.81B	$3.29B	$1.94B	$1.34B
Working Capital	$723.00M	$548.00M	$157.00M	$680.00M
Net Debt	$1.58B	$1.78B	$1.86B	$2.00B

XRAY Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$517.00M	$377.00M	$461.00M	$235.00M
Capital Expenditure	-$149.00M	-$149.00M	-$180.00M	-$131.00M
Free Cash Flow	$368.00M	$228.00M	$281.00M	$104.00M
Depreciation & Amortisation	$328.00M	$343.00M	$349.00M	$352.00M
Stock-Based Compensation	$59.00M	$46.00M	$39.00M	$33.00M
Investing Cash Flow	-$138.00M	-$89.00M	-$197.00M	-$132.00M
Financing Cash Flow	-$329.00M	-$307.00M	-$302.00M	-$80.00M
Dividends Paid	-$104.00M	-$116.00M	-$126.00M	-$128.00M
Share Repurchases	-$150.00M	-$300.00M	-$250.00M	$0.00
Net Change in Cash	$50.00M	-$19.00M	-$38.00M	$23.00M

XRAY Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$879.00M	$936.00M	$904.00M	$961.00M	$880.00M	$898.00M
Cost of Revenue	$413.00M	$446.00M	$463.00M	$518.00M	$453.00M	$405.00M
Gross Profit	$466.00M	$490.00M	$441.00M	$443.00M	$427.00M	$493.00M
Research & Development	$36.00M	$37.00M	$37.00M	$40.00M	$44.00M	$45.00M
Selling, General & Admin	$360.00M	$344.00M	$358.00M	$378.00M	$353.00M	$365.00M
Operating Expenses	$396.00M	$381.00M	$395.00M	$418.00M	$397.00M	$410.00M
Operating Income	$70.00M	$109.00M	$46.00M	$25.00M	$30.00M	$83.00M
EBITDA	$142.00M	-$41.00M	-$115.00M	-$32.00M	$61.00M	$179.00M
Pretax Income	$44.00M	-$153.00M	-$230.00M	-$147.00M	-$42.00M	$72.00M
Income Tax	$25.00M	-$109.00M	$198.00M	-$2.00M	-$32.00M	$36.00M
Net Income	$20.00M	-$45.00M	-$427.00M	-$146.00M	-$10.00M	$37.00M
Diluted EPS	0.10	-0.22	-2.14	-0.74	-0.05	0.18
Diluted Shares	199.80M	199.30M	199.50M	199.60M	199.90M	200.50M

XRAY Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$398.00M	$359.00M	$363.00M	$326.00M	$190.00M	$239.00M
Receivables	$604.00M	$646.00M	$654.00M	$737.00M	$622.00M	$620.00M
Inventory	$612.00M	$675.00M	$686.00M	$642.00M	$659.00M	$665.00M
Current Assets	$1.98B	$1.97B	$2.07B	$2.02B	$1.84B	$1.93B
Total Assets	$6.05B	$6.07B	$5.65B	$5.43B	$5.23B	$5.20B
Current Liabilities	$1.79B	$1.17B	$1.41B	$1.34B	$1.21B	$1.19B
Long-Term Debt	$1.59B	$2.22B	$2.02B	$2.02B	$2.01B	$2.00B
Total Debt	$2.42B	$2.49B	$2.48B	$2.47B	$2.33B	$2.31B
Total Liabilities	$4.04B	$4.11B	$4.17B	$4.09B	$3.91B	$3.85B
Retained Earnings	-$848.00M	-$925.00M	-$1.39B	-$1.56B	-$1.57B	-$1.54B
Shareholders' Equity	$2.01B	$1.96B	$1.48B	$1.34B	$1.32B	$1.35B
Working Capital	$185.00M	$800.00M	$667.00M	$680.00M	$638.00M	$743.00M
Net Debt	$1.94B	$2.04B	$2.03B	$2.00B	$2.05B	$1.99B

XRAY Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$7.00M	$48.00M	$79.00M	$101.00M	$40.00M	$99.00M
Capital Expenditure	-$19.00M	-$32.00M	-$39.00M	-$41.00M	-$52.00M	-$44.00M
Free Cash Flow	-$12.00M	$16.00M	$40.00M	$60.00M	-$12.00M	$55.00M
Depreciation & Amortisation	$79.00M	$88.00M	$92.00M	$93.00M	$79.00M	$85.00M
Stock-Based Compensation	$10.00M	$9.00M	$6.00M	$8.00M	$8.00M	$9.00M
Investing Cash Flow	-$17.00M	-$34.00M	-$36.00M	-$45.00M	-$53.00M	-$39.00M
Financing Cash Flow	$123.00M	-$68.00M	-$36.00M	-$99.00M	-$119.00M	-$11.00M
Dividends Paid	-$32.00M	-$32.00M	-$32.00M	-$32.00M	-$32.00M	$0.00
Share Repurchases	—	—	$0.00	$0.00	—	—
Net Change in Cash	$113.00M	-$54.00M	$7.00M	-$43.00M	-$132.00M	$49.00M

Market Snapshot

About

DENTSPLY SIRONA is a leading manufacturer of professional dental products and technologies. The company provides equipment, instruments, consumables, and digital dentistry solutions to dental professionals worldwide. DENTSPLY SIRONA serves the dental, oral health, and medical device markets with a comprehensive portfolio of trusted brands.